Abstract:Background: Hepatocellular carcinoma (HCC) is the fifth most common tumor worldwide. Because many hepatocellular carcinomas are already unresectable at the time of initial diagnosis, percutaneous tumor ablation has become established in recent decades as a curative therapeutic approach for very early (BCLC 0) and early (BCLC A) HCC. The aim of this paper is to provide a concise overview of the percutaneous local ablative procedures currently in use, based on their technical characteristics as well as clinical relevance, taking into account the current body of studies. Materials and methods: The literature search included all original papers, reviews, and meta-analyses available via MEDLINE and Pubmed on the respective percutaneous ablation procedures; the primary focus was on randomized controlled trials and publications from the last 10 years. Results and conclusions: Radiofrequency ablation (RFA) and microwave ablation (MWA) are well-established procedures that are considered equal to surgical resection in the treatment of stage BCLC 0 and A HCC with a diameter up to 3 cm due to their strong evidence in international and national guidelines. For tumors with a diameter between 3 and 5 cm, the current S3 guidelines recommend a combination of transarterial chemoembolization (TACE) and thermal ablation using RFA or MWA as combination therapy is superior to thermal ablation alone in tumors of this size and shows comparable results to surgical resection in terms of overall survival. Alternative, less frequently employed thermal procedures include cryotherapy (CT) and laser ablation (LA). Non-thermal procedures include irreversible electroporation (IRE), interstitial brachytherapy (IBT), and most recently, electrochemotherapy (ECT). Due to insufficient evidence, these have only been used in individual cases and within the framework of studies. However, the nonthermal methods are a reasonable alternative for ablation of tumors adjacent to large blood vessels and bile ducts because they cause significantly less damage to these structures than thermal ablation methods. With advances in the technology of the respective procedures, increasingly good evidence, and advancements in supportive techniques such as navigation devices and fusion imaging, percutaneous ablation procedures may expand their indications for the treatment of larger and more advanced tumors in the coming years. Key points: · RFA and MWA are considered equal to surgical resection as a first-line therapy for the curative treatment of stage BCLC 0 and A HCCs with a diameter of up to 3 cm.. · For HCCs with a diameter between 3 and 5 cm, a combination of TACE and RFA or MWA is recommended. This combination therapy yields results comparable to those of surgical resection in terms of overall survival.. · Due to insufficient evidence, alternative ablation methods have only been used in individual cases and within the framework of studies. However, nonthermal methods, such as IRE, IBT, and, most recently, ECT, are a reasonable alternative for ablation of HCCs adjacent to large blood vessels and bile ducts because they cause significantly less damage to these structures than thermal ablation methods.. Citation format: · Luerken L, Haimerl M, Doppler M et al. Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma. Fortschr Röntgenstr 2022; 194: 1075 - 1086.

Application of Thermal Ablation in Patients with Primary Hepatic Carcinoma and its Cognition from Physicians and Managers

Expert Consensus Workshop Report: Guidelines for Thermal Ablation of Thyroid Tumors (2019 Edition)

Standardization of Thermal Ablation in Treatment of Liver Tumor

Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma

Progress of Ultrasound-Guided Radiofrequency Ablation of Hepatocellular Carcinoma in Difficult Areas

Thermal ablation for hepatic tumors in high-risk locations

The latest research progress on minimally invasive treatments for hepatocellular carcinoma

[Expert consensus and operation specifications for thermal ablation in the treatment of primary hyperthyroidism]

Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns

Clinical Analysis of Ultrasound-guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma

Thermal ablation of hepatocellular carcinoma in patients with abnormal coagulation function

Thermal Ablation of Hepatic Hemangioma: A Multi-Center Experience with Long-Term Outcomes

Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma

Risk factors of complications after thermal ablation for hepatocellular carcinoma: the role of assessment of liver background

Chinese Expert Consensus on Co-Ablation System for the Treatment of Primary Liver Cancer(2023 Edition)

Chinese Clinical Practice Guidelines for Ultrasound-Guided Irreversible Electroporation of Liver Cancer (version 2022)

Prevention and Treatment of Major Complications in Liver Cancer Patients after Thermal Ablation

Clinical Practice Guideline for Image-Guided Multimode Tumour Ablation Therapy in Hepatic Malignant Tumours

[Efficacy of Radiofrequency Ablation of 343 Patients with Hepatic Tumor and the Relevant Complications].

[Clinical Application of Ultrasound-Guided Radiofrequency Ablation for Primary Hepatocellular Carcinoma Near the Liver Surface].

Initial Incomplete Thermal Ablation Is Associated With a High Risk of Tumor Progression in Patients With Hepatocellular Carcinoma